Acute Myeloid Leukemia | Tumor

Paying it Forward in the Flow

July 16th 2021, 4:00pm


A woman shares the story of her journey with multiple cancer types, including the same one that her mother died from.

Palliative Care Improves Coping in Patients with A Certain Type of Leukemia

June 9th 2021, 9:00pm


Introducing integrated palliative care to patients with a certain type of leukemia was shown to facilitate active coping strategies, which could improve a patient’s quality of life.

Potential Genetic Target Found for Treating Pediatric Leukemia

May 24th 2021, 9:00pm


Scientists have identified a potentially valuable genetic target in children with acute myeloid leukemia that could lead to further studies in immunotherapy drugs for the disease.

Childhood Down Syndrome and Acute Myeloid Leukemia Association ‘Greater Than Previously Reported’

May 12th 2021, 1:00pm


An analysis of more than 3.5 million children born between January 1996 and December 2016 demonstrated a stronger association between Down syndrome and acute myeloid leukemia risk than has been previously reported.

Early Study Results Show Novel Therapy Safe and Effective in Relapsed/Refractory Acute Myeloid Leukemia

May 11th 2021, 6:00pm


Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.

Venclexta With a Hypomethylating Agent Shows Promise for Patients with Acute Myeloid Leukemia

May 6th 2021, 9:00pm


Compared to a hypomethylating agent alone, combining the agent with Venclexta improved complete remission rates in patients with blast-phase myeloproliferative neoplasm.

Why the COVID-19 Vaccine is Important for Patients with Blood Cancers

April 27th 2021, 9:00pm


Patients with blood cancers are at a much higher risk of complications if they contract COVID-19, says an expert from the Leukemia & Lymphoma Society (LLS).

Post-Traumatic Stress Disorder Prevalent in Patients with Acute Myeloid Leukemia

April 21st 2021, 6:00pm


Patients with acute myeloid leukemia experience post-traumatic stress disorder symptoms including intrusion, avoidance and hypervigilance one month after diagnosis.

FDA Approves Expanded Label of Vyxeos to Include Pediatric Patients with Secondary AML

March 31st 2021, 12:30am


The agency granted approval to the revised label of Vyxeos to now include treatment for newly diagnosed therapy-related acute myeloid leukemia or disease with myelodysplasia-related changes in pediatric patients aged 1 and older.

‘Attitude is Everything’ When Dealing with Cancer

February 11th 2021, 4:00pm


This week on the “CURE Talks Cancer” podcast, we spoke with Nicole Schulz, who was diagnosed with acute myeloid leukemia at the age of 14, about how her life changed as a result of her treatment and why she now lives life to the fullest.